Sepsis Et Causa Empiema Dekstra Et Causa Community Acquired Pneumonia Dengan Komorbid Diabetes Melitus
Abstract
Keywords
Full Text:
PDFReferences
Ahmed AE, Yacoub TE 2010. Empyema thoracis [review]. Clinical medicine insight: circulating, respiratory and pulmonary medicine.;4: 1-8.
Backer D, Dorman T 2017. Surviving sepsis guidelines: a continuous move toward better care of patients with sepsis. JAMA.; 317(8): 807-8.
Bernard GR, Vincent JL, Laterre PF, LaRosa S, Dhainaut JP, Rodriguez AL, et al., 2001. Efficacy and safety of recombinant human activated protein c for severe sepsis. N Eng J Med; 344 (10): 699-709.
Chen K dan Pohan HT 2007. Penatalaksanaan Syok Septik dalam Sudoyo, Aru W. Setiyohadi, Bambang. Alwi, Idrus. Simadibrata K, Marcellus. Setiati, Siti. Buku Ajar Ilmu Penyakit Dalam Jilid I Edisi IV. Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit Dalam FKUI. Pp: 187-9
Christopher W Seymour, Matthew R Rosengart 2015. Septic shock Advances in Diagnosis and Treatment. Jama.
Hari sankar, Philips 2016. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Jama.
Jeffrey E, Michael A 2016. Sepsis pathophysiologycal and clinical management. BMJ.
Light RW 2011. Parapneumonic Effusions and empyema. Bab 12. Pleural Disease. Fifth edition. Philadelphia, USA:179-210.
Mervyn Singer, clifford 2016. The Third International Consensus Definitions for Sepsis and Septic Shock. JAMA.
Mossie A 2013. Pathofisiology of septic. World Journal of Medicine and Medical Science.
Munford RS 2008. Severe Sepsis and Septic Shock. In A.Feluci,et al Harrison’s Prinsiple of Internal 1 Medicine, 17th ed.New york: Mc Graw-Hill Medica1, Ch .265.
Meissner M 2014. Update on Procalsitonin Measurement, Ann Lab Med: 34:263-273.
Mehta Y, Kochar G 2017. Sepsis and septic shock. Journal of Cardiac Critical Care TSS; 1(1): 3-5.
National Clinical Effectiveness Committee (NCEC) 2014. Sepsis Management National Clinical Guideline; No.6, An Roine Slainte Departement of Health, Ireland.
Purwitasari M, Burhan E, Soepandi PZ 2013. Peranan prokalsitonin pada pneumonia komunitas. Indones J Infect Dis ;33–41.
Perhimpunan Dokter Paru Indonesia (PDPI) 2014. Pneumonia Komuniti: Pedoman Diagnosis & Penatalaksanaan di Indonesia. Perhimpun Dr Paru Indones;6.
Perkumpulan Endokrinologi Indonesia (PERKENI) 2015. Konsensus Pengelolaan dan Pencegahan Diabetes Mellitus tipe 2 di Indonesia. Jakarta: PB PERKENI; p.75-7.
Sameraro N, Ammollo CT, Sameraro F 2012. Sepsis, Thrombosis and Organ Disfunction, Thrombosis Research, Elseivers; 129: 290-5.
Sahn SA 2007. Diagnosis and management of parapneumonic effusions and empyema. Clin Infect Dis; 45:1480-6.
Shiferaw B, Bekele E, Kumar K, Boutin A, Frieri M 2016. The Role of Procalsitonin as A Biomarker in Sepsis: J.Infect Dis Epidemiol,vol 2(1);2: 006.
Shrestha K, Shah S, Tulung S, Karki b, Pokhrel DP 2011. Envolving experience in the management of emphyema thoracis. Kathmandu Univ Med J;33(1):5-7.
Yanti WS, Loehoeri S 2003. Profil pasien yang di Diagnosis Sepsis di RS Dr.Sardjito. Dalam Ilmu kedokteran Berkala, Yogyakarta,; 35:4:225-30.
Yu H 2011. Management of pleural effusion, empyema and lung abcess. Seminars in Interventional radiology; 28: 75-86.
Z Fadhil 2016.Definition, Incidence and Evolution of Sepsis & Septic Shock. Open Acces.
DOI: https://doi.org/10.33476/jky.v28i2.1418
Refbacks
- There are currently no refbacks.
Copyright (c) 2020 YARSI Medical Journal

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
__________________________________________________________________________________________
Copyright of Jurnal Kedokteran YARSI.Powered by OJS.
This work is licensed under a Creative Commons Attribution- NonCommercial 4.0 International License.